$HCM #Hutchison China MediTech ADR Hutchison China MediTech - Eye of the tiger: Hutchison China MediTech (HCM) is on the brink of global launches of two assets from its internally developed oncology portfolio. In 2022 we expect US… https://t.co/GXsWojkU2H #equity #stocks https://t.co/z5e6SAcdYP